See other companies on Welcome to the Jungle

Cellares

Cell therapy manufacturing services provider

Cellares logo
201-500 employees
  • Healthcare
  • B2B
  • Biology
  • Social Impact
The East Side, South San Francisco, CA

Company mission

To accelrete access to life-saving cell therapies.

Top investors

Few candidates hear
back within 2 weeks

44% employee growth in 12 months

Our take

There is a significant need for efficient, scalable manufacturing of cell therapies in the biopharmaceutical industry. As demand for advanced treatments like CAR T-cell therapies rises, traditional manufacturing methods often struggle with scalability, high costs, and process failures, limiting patients' access to these lifesaving therapies.

In response, Cellares has developed the CEll Shuttle platform, an automated system designed for high-throughput cell therapy production. The Cell Shuttle can manufacture 16 batches simultaneously, cutting batch costs by up to 50%. By integrating advanced technologies for flow cytometry and cell sorting, Cellares enhances operational efficiency, providing comprehensive solutions that accelerate access to therapies.

Partnering with industry leaders like Kite, Bristol Myers Squibb, and Cabeletta Bio further strengthens its market position, showcasing the platform's potential impact. Along with over $355M in funding and a commercial-scale facility in New Jersey, Cellares is well-prepared to scale operations and meet global demand, positioning itself for future growth in the evolving cell therapy landscape.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Holidays & Flexible Vacation
  • Parental Leave
  • Comprehensive Healthcare
  • 401k + Company Match
  • Catered Onsite Meals
  • Premium Technology
  • EV Charging
  • Professional Development

Company values

  • Integrity: We honor commitments, communicate openly, and demonstrate the highest ethical standards
  • Innovation: We create novel solutions to high-value problems
  • Growth Mindset: We value curiosity, the willingness to learn, and the courage to grow beyond ourselves while emrbacing change
  • Collaboration: We work as one team, encourage vulnerability & diverse perspectives, and treat each otherwith authenticity & respect
  • Passion: We are dedicated to doing meaningful work, achieving exceptional results, and having fun along the journey
  • Quality: We are committed to world class Quality in everything we do and build a culture that promotes transparency, ownership, and regulatory compliance based on our customers' needs

Funding (last 2 of 3 rounds)

Aug 2023

$255m

SERIES C

May 2021

$82m

SERIES B

Total funding: $355m

This company has top investors

Leadership

Fabian Gerlinghaus

(Co-Founder & CEO)

Graduated from the University of Munich with a Master's Degree in Aerospace Engineering. Prior to co-founding Cellares in 2019, they were the CHief Innovation officer at Synthego.

Jobs (3)

All locations

Data

Other Engineering